People living with human immunodeficiency virus (HIV) are at higher risk of morbidity and mortality due to vaccine-preventable diseases. At the same time, they are less likely to respond to vaccinations, and might have a higher rate of vaccine adverse event and faster waning of protective effect. International and national guidelines emphasize the importance of vaccinating people living with HIV against respiratory system disease pathogens including seasonal influenza, Streptococcus pneumoniae, and COVID-19, as well as against sexually transmitted infections, i.e., Hepatitis A and B (HAV, HBV) and human papillomavirus (HPV). This narrative review aims to provide a comprehensive examination of the current knowledge regarding the immune and clinical responses elicited by vaccinations in the older adult population living with HIV.
Type 1 diabetes mellitus is an autoimmune disease in which patients with a genetic predisposition develop antibodies against pancreatic islet β-cells under certain conditions, resulting in the loss of insulin production. Genetic, infective, dietary, and humoral factors are potential predictors associated with the risk of β-cell destruction. The coexistence of another autoimmune disease can be found in up to 29% of patients with type 1 diabetes. The most common disorders are autoimmune thyroid disease, coeliac disease, autoimmune gastritis, pernicious anaemia, and vitiligo. Other conditions that can coexist with type 1 diabetes are rheumatoid arthritis, autoimmune hepatitis, alopecia, and psoriasis. This coexistence is often present in autoimmune polyendocrine syndromes. The likelihood of developing an autoimmune disease increases with age, and it is higher in the female population. Concomitant autoimmune diseases can negatively affect the patient’s quality of life and metabolic control of diabetes, potentially increasing the risk of micro- or macrovascular complications and the frequency of hypoglycaemic episodes. Determining organ-specific antibodies is useful in the active search for autoimmune diseases in type 1 diabetes patients to identify individuals at increased risk for the disease. This article aims to summarise the most recent research on type 1 diabetes-associated autoimmune disorders, including screening, diagnosis, and treatment principles.
Introduction: Hyponatremia is a common finding in hospitalized patients, especially the elderly. Symptoms of hyponatremia can vary depending on the concentration of sodium in serum as well as the dynamics of its escalation. Hyponatremia can have many etiologies, including medication, vomiting, or diarrhea, and central nervous system disorders, including tumors, trauma, and infections. Case report: In this case, we present a 74-year-old patient who was admitted to the Department of Internal Medicine with symptomatic, acute, and severe hyponatremia in the course of the syndrome of inappropriate antidiuretic hormone secretion due to varicella zoster virus meningoencephalitis. Clinical improvement and normalization of natremia occurred after the initiation of causal treatment. Conclusion: Given the complexity of the potential causes of hyponatremia and the variety of treatments available, it is essential to thoroughly consider the possible reasons for electrolyte abnormalities, including uncommon ones such as central nervous system infections.
Severe growth hormone deficiency (GHD) in adults is associated with unfavorable metabolic disturbances and adversechanges in body composition, contributing to increased cardiovascular risk and impaired quality of life. Although recombinant humangrowth hormone (rhGH) replacement therapy is an established treatment, data reflecting its effects under real-world clinical conditionsin Poland remain limited. This retrospective, real-world study included adult patients with severe GHD treated with rhGH within the nationaldrug program at a single tertiary endocrine center. Serum insulin-like growth factor 1 (IGF-1), lipid profile, glycemic parameters,and body composition assessed by bioelectrical impedance analysis were evaluated at baseline, after 6 and 12 months of therapy, and atthe last follow-up. Recombinant human GH therapy was associated with a sustained increase in serum IGF-1 concentrations throughout the observationperiod. Treatment was accompanied by a reduction in total cholesterol and low-density lipoprotein cholesterol levels, while norelevant changes were observed in high-density lipoprotein cholesterol, triglycerides, or glycated hemoglobin. After 12 months of therapy,a decrease in total fat mass and body fat percentage was observed, along with an increase in relative muscle mass. Favorable regionalchanges in body composition involved the trunk as well as upper and lower limbs. No meaningful changes were detected in absolutemuscle mass, bone mass, or total body water. In adults with severe GHD, rhGH replacement therapy administered under routine clinical practice conditions is associated with beneficial changes in lipid profile and favorable body recomposition, characterized by reduced adiposity and increased relative muscle mass. These findings support the effectiveness of long-term, individualized rhGH therapy in adult patients with GHD.
Background: Management of giant pyogenic liver abscesses (PLA) remains challenging, particularly in culture-negative cases, where clinical improvement may not reflect adequate local disease control. Case Description: A 65-year-old woman with well-controlled type 2 diabetes mellitus presented with several weeks of systemic symptoms, marked inflammatory response, cholestatic liver injury, and acute kidney dysfunction. Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) revealed a large, multiloculated hepatic lesion measuring approximately 10 cm, consistent with a giant PLA. Empirical broad-spectrum antimicrobial therapy resulted in rapid clinical and biochemical improvement; however, follow-up imaging demonstrated further enlargement of the abscess. Microbiological cultures from blood, urine, and the abscess cavity remained negative. In view of radiological progression, CT-guided percutaneous catheter drainage was performed, resulting in effective evacuation and subsequent lesion regression. Long-term follow-up confirmed complete resolution without recurrence. Conclusions: This case highlights that clinical and laboratory improvement alone may be insufficient to assess treatment response in giant, culture-negative PLA. Serial imaging plays a key role in identifying inadequate local disease control and guiding timely escalation to image-guided intervention.